We aimed to evaluate the value of novel high-resolution impedance manometry (HRIM) metrics, bolus fl ow time (BFT), and esophagogastric junction (EGJ) contractile integral (CI), as well as EGJ pressure (EGJP) and the integrated relaxation pressure (IRP), as indicators of treatment response in achalasia.
INTRODUCTION
Achalasia is a primary esophageal motor disorder that typically presents with symptoms of dysphagia, regurgitation, and/or chest pain. Achalasia is characterized and diagnosed by manometry demonstrating impaired deglutitive lower esophageal sphincter (LES) relaxation and absent peristalsis ( 1 ) . As the symptoms of achalasia involve esophagogastric junction (EGJ) outfl ow obstruction and subsequent esophageal bolus retention and stasis, the management of achalasia targets relieving the obstruction at the EGJ by pneumatic dilation (PD), laparoscopic Heller myotomy (LHM), or more recently, per-oral endoscopic myotomy (POEM) (2) (3) (4) . Although treatment is oft en successful in improving both symptoms and esophageal emptying, follow-up of patients is essential to confi rm sustained treatment response, to assess the need for further treatment, and hopefully to prevent progression to advanced disease (e.g., dilated, sigmoid esophagus) ( 2-4 ).
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Dustin A. Carlson , MD, MS 1 , Zhiyue Lin , BS 1 Although manometry is considered the optimal test to diagnose achalasia, follow-up aft er treatment relies heavily upon symptom assessment. However, symptom severity can correlate poorly with objective testing (esophagram and/or manometry) and previous studies have shown that esophageal stasis as measured with timed-barium esophagram (TBE) is a better predictor of treatment failure than symptom severity ( 5-7 ). Current recommendations for post-treatment follow-up evaluation in patients with achalasia involves intermittent assessment with TBE and/or manometry ( 2 ) . Studies utilizing the conventional manometric measurement of LES pressures have demonstrated an association with improved long-term clinical outcomes aft er treatment (8) (9) (10) ; however, reports confl ict on the utility of conventional manometry to evaluate clinical outcomes. Th ough high-resolution manometry (HRM) facilitated improved diagnosis of achalasia utilizing the 4 s integrated relaxation pressure (IRP) compared with conventional manometric measures, the association of IRP measurement with achalasia treatment outcomes has yielded varied results ( 7, 11, 12 ) .
High-resolution impedance manometry (HRIM) incorporates multichannel, intraluminal impedance sensors onto the HRM catheters and allows for the simultaneous assessment of intraluminal pressures, bolus presence, and bolus fl ow ( 13, 14 ) . A study using concurrent HRIM and esophageal intraluminal ultrasound demonstrated that impedance measurement can assess EGJ opening and esophageal emptying ( 13 ) . On the basis of this concept, we developed and validated a novel HRIM metric to specifi cally assess fl ow across the EGJ: the bolus fl ow time (BFT) ( 15 ) . Utilizing simultaneous videofl uoroscopy with HRIM, bolus fl ow across the EGJ was observed on fl uoroscopy when two criteria were met: (i) bolus was present, which was associated with a decrease in impedance and (ii) a preferential pressure gradient existed across the EGJ such that pressure in the distal esophagus was greater than at the crural diaphragm. Both of these criteria were incorporated into a computer-based algorithm for automated calculation of the BFT. We recently reported that the BFT was a useful measure in patients with suspected achalasia and borderline IRP measures and that BFT had a better symptom-association than basal EGJ pressure (EGJP) or IRP in patients with achalasia before intervention ( 16 ) .
Another novel HRM metric of basal EGJ pressure is the EGJ contractile integral (EGJ-CI), which incorporates an intragastric pressure reference and the respiratory cycle to assess the barrier function of the EGJ ( 17 ) . Reduced EGJ-CI was initially reported to be associated with gastroesophageal refl ux disease ( 17, 18 ) . Recently, a greater-than-normal EGJ-CI was reported in patients with newly-diagnosed achalasia and a reduction in EGJ-CI was observed following Heller myotomy ( 19 ) .
Th erefore, we hypothesized BFT and EGJ-CI would be well suited to assess patients with achalasia during followup aft er treatment. We aimed to evaluate the value of BFT and EGJ-CI in addition to the established HRM metrics of EGJP and IRP, in assessing clinical outcomes in patients with achalasia during follow-up aft er treatment with PD or myotomy.
METHODS

Subjects
We prospectively recruited and evaluated patients with achalasia and previous treatment with PD, LHM (oft en with Dor or Toupet fundoplasty), and/or POEM returning for follow-up or referred from elsewhere. A total of 75 consecutive patients (without hiatal hernia > 2 cm) evaluated between April 2013 and December 2015 that completed HRIM, Eckhardt score (ES), and TBE were included in analysis, noting the time interval from most recent PD or myotomy. When available, HRM performed before intervention was evaluated according to the Chicago Classifi cation ( 1 ) . Th e study protocol was approved by the Northwestern University Institutional Review Board.
Study protocol
Aft er a minimum 6 h fast, HRIM studies were completed using a 4.2 mm outer diameter solid-state assembly with 36 circumferential pressure sensors at 1 cm intervals and 18 impedance segments at 2 cm intervals (Medtronic Inc, Shoreview, MN). Th e HRIM assembly was placed transnasally and positioned to record from the hypopharynx to the stomach with approximately three intragastric pressure sensors. Th e HRIM protocol included a 5 min baseline recording, 10×5 ml swallows in a supine position, and fi ve 5 ml swallows in the upright position using 50% saline for test swallows at 20-30 s intervals.
Data analysis
Manometry studies were analyzed using ManoView version 3.0 analysis soft ware to measure EGJP, IRP, distal CI (DCI), and distal latency. Th e EGJP was measured at end-expiration using the isobaric contour tool with pressure referenced to gastric pressure during the supine, baseline recording over a period of easy breathing without swallows. Th e IRP was the mean pressure of four contiguous or non-contiguous seconds of maximal relaxation during the 10 s deglutitive period as referenced to gastric pressure; the median IRP of 10 supine swallows was used for each patient. Esophageal motility diagnoses were in accordance with the Chicago Classifi cation v3.0, using a median IRP of>15 mm Hg as the upper-limit of normal ( 1 ) . Although the Chicago Classifi cation was designed and intended for patients without previous surgery, we utilized the classifi cation scheme in our post-treatment cohort to objectively describe the motility patterns observed on follow-up.
Th e HRIM data for each subject were exported to MATLAB (Th e MathWorks Inc., Natick, MA) to apply to a customized program to calculate the BFT. To measure the BFT, three impedance and three manometry signals were placed through the EGJ at 1 cm intervals (thus, impedance and pressure signals were interpolated by the analysis soft ware). Th e distal impedance and manometry signal was positioned within the hiatus as identifi ed by crural contractions ( 15, 16 ) . Example swallows are displayed in Figure 1 . Using the impedance signals, the duration of bolus presence was determined: Th e onset of bolus presence was defi ned as the point at which the impedance dropped to 90% of the nadir; the off set of bolus presence was defi ned as the return to 50% of the impedance baseline. Using the three manometry signals, periods of a trans-EGJ fl ow-permissive pressure gradient (i.e., when the esophageal pressure was greater than both the crural and intragastric pressure signals) were determined. Th e BFT was then derived as the sum of all periods meeting the criteria of both bolus presence and a fl owpermissive pressure gradient time. If the impedance drop was not greater than 50% at each axial location and/or a fl ow-permissive pressure gradient was not achieved (as in Figure 1b ), the BFT was considered to be zero. Th e median BFT value of the fi ve upright swallows was utilized for each patient. Previous study of asymptomatic volunteers demonstrated a median (interquartile range, IQR) BFT of 3.2 s (2.3-3.9 s) for upright swallows; lower BFT values indicate reduced esophageal emptying ( 16 ) .
Th e EGJ-CI was measured during a similar study period as EGJP by positioning the DCI-tool domain to contain the proximal and distal borders of the EGJ and over a duration of exactly three respiratory cycles ( 17 ) . Th e isobaric contour was set to 2 mm Hg above the mean gastric pressure. Th e EGJ DCI value (mm Hg s cm) was then divided by the duration (seconds) of the total measurement domain to generate the EGJ-CI (mm Hg cm). A previous study including asymptomatic volunteers reported a median (IQR) EGJ-CI of 39 mm Hg cm (25-55) ( 17 ) .
Symptom assessment
Symptoms were assessed with the ES ( 8 ) . Th e ES (range 0-12) was generated by the sum of scores for dysphagia, chest pain, and regurgitation based on the frequency of each symptom (0: never, 1: occasional, 2: daily, 3: with each meal) plus a score based on the degree of weight loss since the last therapeutic intervention (0: none, 1:<10 lbs, 2: 10-20 lbs, 3:>20 lbs). Patients reporting an ES≤3 were considered as a good symptomatic outcome; those with ES>3, a poor symptomatic outcome.
Timed-barium esophagram
Timed-barium esophagrams were performed in the upright position with x-ray images of the esophagus obtained at 1, 2, and 5 min aft er ingestion of 200 ml of low-density (45% weight to volume) barium sulfate. Th e height of the barium column was measured vertically from the EGJ. A column height<5 cm at 5 min was considered a good radiographic outcome whereas a column height≥5 cm was considered a poor radiographic outcome ( 7, 20 ) .
A combined (symptomatic and radiographic) outcome assessment was performed by considering a good outcome for patients with ES≤3 and TBE 5 min column height<5 cm and a poor outcome in patients with ES>3 or TBE 5 min column height≥5 cm.
Statistical analysis
Descriptive statistics for all continuous and ordinal measures were presented as median and IQR, unless otherwise stated. Outcome groups were compared using the Mann-Whitney U test for continuous variables) and χ 2 or Fischer's Exact tests for dichotomous and categorical variables. For primary symptom and radiographic outcomes (good ES and good TBE, as defi ned above), a series of logistic regression models were employed and corresponding receiver-operating characteristic (ROC) curves were generated by plotting the sensitivity by false positive rate (1-specifi city) for incremental value increases of each HRIM metric. Th e optimal threshold value for each metric was chosen as the closest value to 100% sensitivity and 0% false positive rate (the 0,1 point on the ROC curve). Analyses assumed a 5% level of statistical signifi cance, and no adjustments were made for multiple hypothesis tests. Table 1 ; 61 patients had their most recent treatment at Northwestern, whereas 14 were referred for evaluation after treatment (two PD, 12 LHM) outside our institution. Nine patients had undergone more than one previous intervention; two patients had received esophageal botulinum toxin injection in the interval since a previous intervention (LHMs) which occurred 6 months and 2 years before follow-up. Table 1 also includes achalasia subtypes based on HRM before intervention; 18 patients had remote previous treatment or manometry at outside institutions which prohibited determination of pre-treatment HRMachalasia subtypes.
RESULTS
Patient characteristics
Patient characteristics by outcome groups are also displayed in Table 1 . Th ere were 36 patients with both good symptomatic and radiographic outcomes and 16 patients that had both poor symptomatic and radiographic outcomes; the remaining 23 had discordant symptomatic and radiographic outcomes. Agreement on outcome between ES and TBE was fair with a kappa statistic of 0.341 (95% confi dence interval 0.12-0.56). Outcome groups diff ered by proportion of intervention (generally with a greater proportion of patients treated with POEM in good than poor outcome groups), follow-up interval (shorter interval duration in good than in poor outcomes), and pre-treatment achalasia subtype (greater proportion of type II and III patients in the good than poor outcomes). Follow-up interval also diff ered across intervention ( P <0.001) such that POEM (median, IQR 8, 7-13 months) had earlier follow-up than PD (22, 10-66 months; P =0.17) and LHM (36, 11-121 months; P <0.001); follow-up interval was similar between PD and LHM ( P =0.272).
Manometry characteristics
Esophageal motility patterns at the follow-up HRIM included 10 patients with type I achalasia, 5 with type II achalasia, 2 with type III achalasia, 4 with EGJ outfl ow obstruction, 31 with absent contractility, 6 with distal esophageal spasm, and 17 with ineff ective esophageal motility; none of the patients met criteria for normal motility. Th us, an achalasia pattern was not present (resolved achalasia pattern) in 58 (77%) and there was some evidence of peristalsis in 21 (28%) patients. Carlson et al.
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(14%); P =0.008), and combined (17/21 (81%) vs. poor: 4/21 (19%); P =0.001) criteria.
High-resolution impedance manometry parameters
Among all patients, the median (IQR) EGJP was 10 mm Hg (6) (7) (8) (9) (10) (11) (12) (13) (14) , IRP was 12 mm Hg (9-15), BFT was 0.61 s (0-1.1), and EGJ-CI was 27.4 mm Hg cm (21.4-46.9). Patients with a resolved achalasia pattern more frequently had a good (42/58, 72%) than poor (16/58, 28%) symptomatic outcome ( P =0.023). However, the proportion of patients with a resolved achalasia pattern was not signifi cantly diff erent between those with a good (37/58, 64%) vs. poor (21/58, 36%; P =0.572) radiographic outcome or with a good (30/58, 52%) vs. poor (28/58, 48%; P =0.278) combined outcome. Th e presence of peristalsis in the post-treatment HRIM study was associated with outcome such that a greater proportion of patients with peristalsis demonstrated good outcomes by symptomatic (20/21 (95%) vs. poor: 1/21 (5%); P <0.001), radiographic (18/21 (86%) vs. poor: 3/21 On the basis of the comprehensive assessment of the ROC curves, an optimal cut-point to discriminate by outcomes was determined to be 11 mm Hg for EGJP, 12 mm Hg for IRP, 0 s for BFT, and 30 mm Hg cm for EGJ-CI. Table 3 reports the sensitivities and specifi cities to predict each outcome using these cut-points.
DISCUSSION
Th e major fi nding of this this study was that the novel HRIM parameter, the BFT, better discriminated patients with achalasia by clinical outcomes aft er treatment compared with another novel HRM metric, the EGJ-CI, and established HRM metrics of EGJP and IRP. As manometry is oft en considered the standard to assess LES function, our fi ndings suggest that utilization of EGJP, IRP, and EGJ-CI at follow-up aft er achalasia intervention are of limited utility and incorporation of BFT may be a better tool to assess treatment eff ectiveness.
Previous studies of post-treatment manometry in achalasia demonstrated that achievement of an EGJP less than 10 mm Hg is predictive of long-term outcome in patients with achalasia following PD ( 8, 9 ) . However, those studies analyzed conventional manometry studies obtained 4 weeks aft er intervention, as opposed to at the time of follow-up (either routine or symptom prompted) and symptom assessment as in the present study. In addition, because objective evidence of esophageal dysfunction (e.g., barium retention) can be incongruent with symptoms, we utilized both symptoms and TBE to assess outcomes in our study ( 5, 6 ) . As HRM is thought to provide a more accurate assessment of LES pressures for diagnosis of achalasia, HRM measurement of EGJP and IRP could provide enhanced assessment in achalasia following treatment ( 7, 11 ) . Comparable to previous studies utilizing conventional manometry, we identifi ed an optimal cut-point of 11 mm Hg for post-treatment EGJP; however, this measure demonstrated poor specifi city for poor clinical outcomes in our study. Although we previously reported that an IRP<15 mm Hg was associated with a good clinical outcome, that association was not demonstrated in the current study that included threetimes as many patients, none of whom were included in the previous report ( 7 ) . Another study assessing HRM 6 and 12 months following POEM demonstrated predominantly good symptomatic We recently demonstrated that the BFT was well correlated with dysphagia in achalasia patients before treatment, and now also demonstrate that BFT measurement can discriminate patient groups by both symptomatic and radiographic outcomes at follow-up aft er treatment ( 16 ) . Given its ability to discriminate patients by clinical outcome measures, the BFT may improve the clinical utility of HRIM in achalasia management. Recommendations for further intervention, including repeat PD, LES myotomy, or even esophagectomy, are complex decisions for both providers and patients. Thus, a multi-modal evaluation of esophageal function is essential to help direct management decisions with each modality contributing to the global assessment of clinical outcome. Our study does not intend to suggest that HRIM replace the symptomatic or radiographic outcome assessment in achalasia, but instead that an improved manometric evaluation would better aid in achalasia management decisions, particularly given the frequent discordance between symptomatic and objective measures of esophageal function ( 5 ) . Impaired esophageal emptying demonstrated by a BFT of zero may support the need for re-intervention, even if EGJP, IRP, and EGJ-CI are low. Further, if a patient with minimal or no symptoms demonstrated a BFT>0, even with elevated EGJP, IRP, and EGJ-CI (such as the patient displayed in Figure 1a with good symptomatic and radiographic outcomes 10 months after PD), it indicates sufficient esophageal function to facilitate emptying, and supports postponing any further therapy. EGJ pressure measures, particularly the IRP, appear to carry their primary value in the initial diagnostic evaluation of achalasia ( 11 ) . Given the variable association of these measures with clinical outcomes, reliance on EGJP, IRP, or EGJ-CI to direct clinical decisions following therapeutic intervention in achalasia should be cautiously applied. Though greater clinical experience and longitudinal patient follow-up will be outcomes (assessed via ES) at both time points, although mean IRP values remained close to 15 mm Hg ( 12 ) .
Th e use of the EGJ-CI in achalasia was reported in a recent study evaluating 21 patients before and aft er Heller myotomy ( 19 ) . Th ey reported that EGJ-CI in patients with achalasia (median, IQR: 67.1 mm Hg·cm, 37.3-113.5) was greater than asymptomatic volunteers (34.7 mm Hg·cm, 26.2-58.3) before intervention and that a reduction in EGJ-CI (to 27 mm Hg·cm, 11.3-43, similar to our study) was observed following myotomy. However, in that study HRM was typically obtained following Heller myotomy for evaluation of both dysphagia and refl ux symptoms and no association with clinical outcomes was reported.
As the primary role of the esophagus is to clear bolus, measurement of pressures at the EGJ (EGJP, IRP, or EGJ-CI) may not completely refl ect esophageal function in patients with achalasia following treatment. Th us, treatment of achalasia to a target IRP<15 mm Hg (or EGJP<10 mm Hg) may provide false assurance of treatment success. Accepting that diff erent target thresholds may be appropriate following treatment (as opposed to use for diagnosis), we used an ROC analysis to optimize these measures. Even so, EGJP, IRP, and EGJ-CI demonstrated limited sensitivity, and more so, specifi city, to predict clinical outcomes. Furthermore, the ROC sensitivity and specifi city results of EGJP and EGJ-CI pressure actually refl ect the counter-intuitive fi nding of higher values associated with good radiographic outcomes.
We again found that the presence of peristalsis on followup HRM was associated with a good clinical outcome ( 7 ). Th is likely refl ects the capacity to generate suffi cient intra-esophageal pressures to establish a fl ow-permissive gradient across the EGJ, evident by the BFT (19/21 patients with peristalsis had a BFT>0 s). For comparison, 10/21 patients with peristalsis had an EGJP<11 mm Hg, 9/21 had an IRP<12 mm Hg, and 7/21 had an EGJ-CI<30 mm Hg·cm. However, when we controlled our ROC curve for the presence of post-treatment peristalsis, the results did not change substantially, suggesting that the BFT may account for additional complexity to esophageal emptying beyond simply the return of peristalsis.
Although measurement of LES pressures (EGJP, IRP, or EGJ-CI) may be partially indicative of an adequate LES-targeted interven- BFT, bolus fl ow time; EGJ-CI, EGJ-contractile integral; EGJP, esophagogastric junction pressure; IRP, integrated relaxation pressure. It is worth noting that the values reported for EGJP and EGJ-CI refl ect measures greater than the optimal cut-point.
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HRIM Metrics and Achalasia Outcomes necessary to support practical application of the BFT, it appears promising as a measure to help direct management decisions in patients with achalasia. Limitations of our study include the restricted availability of BFT, as it involves the use of both HRM with impedance and a customized MATLAB program. Although this currently limits the generalizability of the study, future incorporation of this metric into HRM-analytic soft ware could off er broader utilization of the BFT. In addition, although commonly used, the ES remains a non-validated symptom assessment tool with its own inherent limitations and dichotomizing both outcome measures may have inaccurately categorized some patients. Furthermore, although the association of clinical factors, such as achalasia subtype or treatment modality, with treatment outcome could be inferred from our results (as in Table 1 ), our study did not intend to assess these associations. Th us, related conclusions are limited by potential biases (such as referral bias and patient motivation for follow-up HRIM resulting in a selection bias) and other uncontrolled factors (e.g., follow-up interval).
In conclusion, the novel HRIM metric, BFT, outperformed the EGJ-CI and traditional HRM metrics of EGJP and IRP to diff erentiate between achalasia outcome groups defi ned by standardized symptomatic (ES) and radiographic (TBE) methods. Although continued longitudinal study of our cohort is required to fully defi ne the utility of these measures, it appears that application of the BFT during the follow-up evaluation may add further insight into esophageal function to help guide patient management in achalasia.
